Dermal Filler - Medical Devices Pipeline Assessment, 2018

GlobalData
129 Pages - GLDATA63627
$4,000.00

Summary

GlobalData's Medical Devices sector report, “Dermal Filler - Medical Devices Pipeline Assessment, 2018" provides an overview of Dermal Filler currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dermal Filler pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Dermal Filler under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Dermal Filler and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Dermal Filler under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date.



Companies Mentioned
Aeon Astron Corporation
Allergan Inc
Allergan Plc
Almirall Ltd
Anika Therapeutics Inc
Bioxis Pharmaceuticals
Celltrix AB
CollPlant Ltd
Dermele Skin Care, LLC
EternoGen Aesthetics LLC
Genzyme Corp
Innovia LLC
Juvenis Ltd
Khorionyx SA
Moma Therapeutics, Inc.
N8 Medical Inc
Oligo Medic Inc
PetVivo Holdings Inc
Regenscientific
Samyang Biopharmaceuticals Corp
Sekisui Medical Co Ltd
Shanghai Haohai Biological Technology Co Ltd
Shin Poong PharmCo Ltd
Sinclair Pharma PLC
Sofregen Medical Inc
TEI Biosciences Inc
University of California Santa Barbara

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Dermal Filler Overview 7
3 Products under Development 8
3.1 Dermal Filler - Pipeline Products by Stage of Development 8
3.2 Dermal Filler - Pipeline Products by Territory 9
3.3 Dermal Filler - Pipeline Products by Regulatory Path 11
3.4 Dermal Filler - Pipeline Products by Estimated Approval Date 13
4 Dermal Filler - Pipeline Products under Development by Companies 14
4.1 Dermal Filler Companies - Pipeline Products by Stage of Development 14
4.2 Dermal Filler - Pipeline Products by Stage of Development 16
5 Dermal Filler Companies and Product Overview 18
5.1 Aeon Astron Corporation Company Overview 18
5.2 Allergan Inc Company Overview 19
5.3 Allergan Plc Company Overview 21
5.4 Almirall Ltd Company Overview 23
5.5 Anika Therapeutics Inc Company Overview 24
5.6 Bioxis Pharmaceuticals Company Overview 25
5.7 Celltrix AB Company Overview 29
5.8 CollPlant Ltd Company Overview 30
5.9 Dermele Skin Care, LLC Company Overview 31
5.10 EternoGen Aesthetics LLC Company Overview 32
5.11 Genzyme Corp Company Overview 33
5.12 Innovia LLC Company Overview 34
5.13 Juvenis Ltd Company Overview 35
5.14 Khorionyx SA Company Overview 36
5.15 Moma Therapeutics, Inc. Company Overview 37
5.16 N8 Medical Inc Company Overview 38
5.17 Oligo Medic Inc Company Overview 39
5.18 PetVivo Holdings Inc Company Overview 40
5.19 Regenscientific Company Overview 42
5.20 Samyang Biopharmaceuticals Corp Company Overview 43
5.21 Sekisui Medical Co Ltd Company Overview 44
5.22 Shanghai Haohai Biological Technology Co Ltd Company Overview 45
5.23 Shin Poong PharmCo Ltd Company Overview 47
5.24 Sinclair Pharma PLC Company Overview 48
5.25 Sofregen Medical Inc Company Overview 54
5.26 TEI Biosciences Inc Company Overview 55
5.27 University of California Santa Barbara Company Overview 56
6 Dermal Filler- Recent Developments 57
6.1 Jul 05, 2018: Sinclair Pharma: Trading Update for the 6 months to 30 June 2018 57
6.2 Jun 04, 2018: SWAG Penis Enhancement Procedure Developed by Top Plastic Surgeon Achieving Optimal Results 58
6.3 May 21, 2018: Nestle Skin Health Announces the FDA Approval of Restylane Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands 59
6.4 May 15, 2018: BTG: Final Results For year ended 31 March 2018 60
6.5 May 09, 2018: FibroGen Reports First Quarter 2018 Financial Results 66
6.6 May 08, 2018: Smith & Nephew: Change of Directorate 68
6.7 May 08, 2018: CollPlant Files U.S. Patent Application for Next Generation Dermal Filler 68
6.8 May 03, 2018: Smith & Nephew First Quarter 2018 Trading Report 68
6.9 May 02, 2018: Anika Reports First Quarter 2018 Financial Results 71
6.10 Apr 30, 2018: Sinclair Pharma: Preliminary results for 12 months ended 31 December 2017 72
6.11 Apr 30, 2018: Sinclair secures €23 million debt facility 75
6.12 Apr 09, 2018: Merz Aesthetics Launches New Belotero Lips Dermal Filler Products 76
6.13 Apr 04, 2018: Namal Nawana appointed Chief Executive Officer of Smith & Nephew 77
6.14 Mar 20, 2018: Governor Abbott Announces Smith & Nephew Adding New Jobs In Fort Worth 78
6.15 Mar 05, 2018: Anika Therapeutics Names Joseph Darling As CEO And Director 79
6.16 Mar 01, 2018: Smith & Nephew: Change in Directorate 80
6.17 Feb 27, 2018: FibroGen Announces Fourth Quarter and Full Year 2017 Financial Results 80
6.18 Feb 21, 2018: Anika Announces Fourth Quarter and Full Year 2017 Financial Results 81
6.19 Feb 16, 2018: Merz North America to Highlight Treatments at American Academy of Dermatology Annual Meeting 82
6.20 Feb 08, 2018: Smith & Nephew Fourth Quarter Trading and Full Year 2017 Results 83
6.21 Jan 31, 2018: Smith & Nephew Appoints Roland Diggelmann As Non-Executive Director 84
6.22 Jan 31, 2018: Appointment of Roland Diggelmann as Non-Executive Director 85
6.23 Jan 16, 2018: Galderma Introduces Restylane Skinboosters 85
6.24 Jan 16, 2018: Sinclair Pharma: Ellanse Approved for Brazil 86
7 Appendix 125
7.1 Methodology 125
7.2 About GlobalData 128
7.3 Contact Us 128
7.4 Disclaimer 128

1.1 List of Tables
Table 1: Dermal Filler - Pipeline Products by Stage of Development 9
Table 2: Dermal Filler - Pipeline Products by Territory 10
Table 3: Dermal Filler - Pipeline Products by Regulatory Path 12
Table 4: Dermal Filler - Pipeline Products by Estimated Approval Date 14
Table 5: Dermal Filler Companies - Pipeline Products by Stage of Development 15
Table 6: Dermal Filler - Pipeline Products by Stage of Development 17
Table 7: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 19
Table 8: BioDermal Filler - Product Status 19
Table 9: BioDermal Filler - Product Description 19
Table 10: Allergan Inc Pipeline Products & Ongoing Clinical Trials Overview 20
Table 11: JUVEDERM Volbella - Product Status 20
Table 12: JUVEDERM Volbella - Product Description 20
Table 13: VYC-25L Hyaluronic Acid Injectable Gel - Product Status 21
Table 14: VYC-25L Hyaluronic Acid Injectable Gel - Product Description 21
Table 15: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 16: HA Threads - Product Status 22
Table 17: HA Threads - Product Description 22
Table 18: Juvederm Volift - Nasolabial Folds - Product Status 23
Table 19: Juvederm Volift - Nasolabial Folds - Product Description 23
Table 20: Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 24
Table 21: Hyaluronic Acid Facial Filler - Product Status 24
Table 22: Hyaluronic Acid Facial Filler - Product Description 24
Table 23: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 24: Next Generation ELEVESS Dermal Filler - Product Status 25
Table 25: Next Generation ELEVESS Dermal Filler - Product Description 25
Table 26: Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview 26
Table 27: CYTOSIAL Deep Wrinkle - Product Status 26
Table 28: CYTOSIAL Deep Wrinkle - Product Description 26
Table 29: CYTOSIAL Medium - Product Status 27
Table 30: CYTOSIAL Medium - Product Description 27
Table 31: Cytosial Volume - Product Status 27
Table 32: Cytosial Volume - Product Description 27
Table 33: Cytosmile - Product Status 28
Table 34: Cytosmile - Product Description 28
Table 35: MTI-12 - Aesthetic Device - Product Status 28
Table 36: MTI-12 - Aesthetic Device - Product Description 29
Table 37: MTI-12 - Surgical Repair - Product Status 29
Table 38: MTI-12 - Surgical Repair - Product Description 29
Table 39: Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview 30
Table 40: Credurance - Product Status 30
Table 41: Credurance - Product Description 30
Table 42: CollPlant Ltd Pipeline Products & Ongoing Clinical Trials Overview 31
Table 43: Next Generation Dermal Filler - Product Status 31
Table 44: Next Generation Dermal Filler - Product Description 31
Table 45: Dermele Skin Care, LLC Pipeline Products & Ongoing Clinical Trials Overview 32
Table 46: Gold Nanoparticle Dermal Filler - Product Status 32
Table 47: Gold Nanoparticle Dermal Filler - Product Description 32
Table 48: EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 33
Table 49: Cellifique - Product Status 33
Table 50: Cellifique - Product Description 33
Table 51: Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview 34
Table 52: Dermal Gel Extra - Product Status 34
Table 53: Dermal Gel Extra - Product Description 34
Table 54: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 35
Table 55: Wrinkle Filler - Product Status 35
Table 56: Wrinkle Filler - Product Description 35
Table 57: Juvenis Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
Table 58: Tenergel - Product Status 36
Table 59: Tenergel - Product Description 36
Table 60: Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview 37
Table 61: Autologous Globin Dermal Filler - Product Status 37
Table 62: Autologous Globin Dermal Filler - Product Description 37
Table 63: Moma Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
Table 64: Restogel-131 - Product Status 38
Table 65: Restogel-131 - Product Description 38
Table 66: N8 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 39
Table 67: Ceragenin-Infused Dermal Filler - Product Status 39
Table 68: Ceragenin-Infused Dermal Filler - Product Description 39
Table 69: Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview 40
Table 70: AntaRep - Product Status 40
Table 71: AntaRep - Product Description 40
Table 72: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 73: Dermal Filler - Product Status 41
Table 74: Dermal Filler - Product Description 41
Table 75: Dermal Filler - Lip - Product Status 42
Table 76: Dermal Filler - Lip - Product Description 42
Table 77: Regenscientific Pipeline Products & Ongoing Clinical Trials Overview 43
Table 78: Renu Soft Tissue Volumizing Filler - Aesthetic - Product Status 43
Table 79: Renu Soft Tissue Volumizing Filler - Aesthetic - Product Description 43
Table 80: Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 44
Table 81: Aesthetic Filler - Product Status 44
Table 82: Aesthetic Filler - Product Description 44
Table 83: Sekisui Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
Table 84: NADGL - Product Status 45
Table 85: NADGL - Product Description 45
Table 86: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
Table 87: QST Gel - Product Status 46
Table 88: QST Gel - Product Description 46
Table 89: Third Generation Matrifill - Product Status 47
Table 90: Third Generation Matrifill - Product Description 47
Table 91: Shin Poong PharmCo Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
Table 92: FreeWink - Product Status 48
Table 93: FreeWink - Product Description 48
Table 94: Sinclair Pharma PLC Pipeline Products & Ongoing Clinical Trials Overview 49
Table 95: Atlean - Product Status 49
Table 96: Atlean - Product Description 50
Table 97: Ellansé Lidocaine - Product Status 50
Table 98: Ellansé Lidocaine - Product Description 50
Table 99: Ellansé-E - Product Status 51
Table 100: Ellansé-E - Product Description 51
Table 101: Ellansé-L - Product Status 51
Table 102: Ellansé-L - Product Description 52
Table 103: Ellansé-M - Product Status 52
Table 104: Ellansé-M - Product Description 52
Table 105: Ellansé-S - Product Status 53
Table 106: Ellansé-S - Product Description 53
Table 107: Perfectha G - Product Status 53
Table 108: Perfectha G - Product Description 54
Table 109: Perfectha Lidocaine - Product Status 54
Table 110: Perfectha Lidocaine - Product Description 54
Table 111: Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 55
Table 112: Silk Protein - Tissue/Dermal Filler - Product Status 55
Table 113: Silk Protein - Tissue/Dermal Filler - Product Description 55
Table 114: TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 56
Table 115: Injectable Dermal Filler - Product Status 56
Table 116: Injectable Dermal Filler - Product Description 56
Table 117: University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 57
Table 118: Needle Free Injector - Product Status 57
Table 119: Needle Free Injector - Product Description 57
Table 120: Glossary 128

1.2 List of Figures
Figure 1: Dermal Filler - Pipeline Products by Stage of Development 9
Figure 2: Dermal Filler - Pipeline Products by Territory 10
Figure 3: Dermal Filler - Pipeline Products by Regulatory Path 12
Figure 4: Dermal Filler - Pipeline Products by Estimated Approval Date 14

$4,000.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838